Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1

Bevacizumab, a VEGF‐targeting monoclonal antibody, may trigger an infiltrative growth pattern in glioblastoma. We investigated this pattern using both a human specimen and rat models. In the human specimen, a substantial fraction of infiltrating tumor cells were located along perivascular spaces in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Cancer
Glavni autori: Falchetti, Maria Laura, D'Alessandris, Quintino Giorgio, Pacioni, Simone, Buccarelli, Mariachiara, Morgante, Liliana, Giannetti, Stefano, Lulli, Valentina, Martini, Maurizio, Larocca, Luigi Maria, Vakana, Eliza, Stancato, Louis, Ricci‐Vitiani, Lucia, Pallini, Roberto
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2018
Teme:
Molecular Cancer Biology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590500/
https://ncbi.nlm.nih.gov/pubmed/30414187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31983
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items